ZA924068B - Monoclonal antibodies and antigen for human melanoma - Google Patents

Monoclonal antibodies and antigen for human melanoma

Info

Publication number
ZA924068B
ZA924068B ZA924068A ZA924068A ZA924068B ZA 924068 B ZA924068 B ZA 924068B ZA 924068 A ZA924068 A ZA 924068A ZA 924068 A ZA924068 A ZA 924068A ZA 924068 B ZA924068 B ZA 924068B
Authority
ZA
South Africa
Prior art keywords
antigen
monoclonal antibodies
human melanoma
melanoma
human
Prior art date
Application number
ZA924068A
Inventor
Ingegerd Hellstrom
Hellstrom Ingegerd
Karl Erik Hellstrom
Erik Hellstrom Karl
Hans Marquardt
Marquardt Hans
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of ZA924068B publication Critical patent/ZA924068B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA924068A 1991-06-05 1992-06-04 Monoclonal antibodies and antigen for human melanoma ZA924068B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71061391A 1991-06-05 1991-06-05

Publications (1)

Publication Number Publication Date
ZA924068B true ZA924068B (en) 1993-02-24

Family

ID=24854790

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA924068A ZA924068B (en) 1991-06-05 1992-06-04 Monoclonal antibodies and antigen for human melanoma

Country Status (7)

Country Link
AU (1) AU2170692A (en)
IE (1) IE921810A1 (en)
IL (1) IL102088A0 (en)
MX (1) MX9202642A (en)
PT (1) PT100568A (en)
WO (1) WO1992021767A1 (en)
ZA (1) ZA924068B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874560A (en) 1994-04-22 1999-02-23 The United States Of America As Represented By The Department Of Health And Human Services Melanoma antigens and their use in diagnostic and therapeutic methods
CA2188432C (en) 1994-04-22 2011-02-01 Yutaka Kawakami Melanoma antigens
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
AT502292B1 (en) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology MELANOMA DIAGNOSIS
US20110300067A1 (en) * 2008-09-09 2011-12-08 Ekaterina Dadachova Methods for increasing efficacy of radioimmunotherapy of melanoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339798C (en) * 1985-02-01 1998-04-07 Alan N. Houghton Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans
GB2188637B (en) * 1986-02-07 1990-11-14 Oncogen Vaccines against melanoma

Also Published As

Publication number Publication date
PT100568A (en) 1993-09-30
WO1992021767A1 (en) 1992-12-10
IL102088A0 (en) 1993-01-14
MX9202642A (en) 1992-12-01
IE921810A1 (en) 1992-12-16
AU2170692A (en) 1993-01-08

Similar Documents

Publication Publication Date Title
HUT66753A (en) Novel antibodies and methods for their use
ZA949227B (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodes
IL108199A0 (en) Monoclonal antibodies against the human il-4 receptor and hybridomas producing the same
ZA957634B (en) Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
IL111926A0 (en) Humanized antibodies and uses thereof
IL89489A0 (en) Chimeric antibodies directed against human carcinoembryonic antigen
GB8910395D0 (en) Human monoclonal antibody and hybridoma producing the same
IL100869A0 (en) Monoclonal ige receptor antibodies
EP0285511A3 (en) Monoclonal antibodies and their uses
EP0977590A4 (en) Human monoclonal antibodies
IL92232A0 (en) Anti-fucosylceramide monoclonal antibody
ZA924068B (en) Monoclonal antibodies and antigen for human melanoma
IL109232A0 (en) Human monoclonal antibodies and processes and materials for making such antibodies
EP0508282A3 (en) Anti-idiotypic monoclonal antibodies
AU9143991A (en) Monoclonal antibody op-g2 and method of use
GB8901832D0 (en) Human monoclonal antibody and its production and use
EP0547631A3 (en) Antibody expression vector and antibodies produced thereby
EP0407586A4 (en) Human monoclonal antibody and process for its preparation
GB9118013D0 (en) Monoclonal antibodies and their use
EP0546634A3 (en) Tumor associated monoclonal antibody 88bv59
GB9204514D0 (en) Monoclonal antibodies and their use
GB9210929D0 (en) Monoclonal antibodies and their use
GB9210930D0 (en) Monoclonal antibodies and their use
GB9210944D0 (en) Monoclonal antibodies and their use
IL104291A0 (en) Antigenic epitopes and antibodies against them